Past and Future Alternatives and Strategies. Trends in the epidemiology of end-stage renal disease over the last decade; P. Landais. Answers to liver graft shortage: hepatocyte transplantation and bioartificial liver; Y. Calmus. Enzymatic and biochemical substitutes to organ transplantation in inborn errors of metabolism; P. Cochat. Tolerance induction; K.J. Wood. Xenotransplantation: immunological advances; G. Blancho. Liver Replacement Therapy. Living donor in liver transplantation as novel graft source; O. Boillot. Ex ...
Read More
Past and Future Alternatives and Strategies. Trends in the epidemiology of end-stage renal disease over the last decade; P. Landais. Answers to liver graft shortage: hepatocyte transplantation and bioartificial liver; Y. Calmus. Enzymatic and biochemical substitutes to organ transplantation in inborn errors of metabolism; P. Cochat. Tolerance induction; K.J. Wood. Xenotransplantation: immunological advances; G. Blancho. Liver Replacement Therapy. Living donor in liver transplantation as novel graft source; O. Boillot. Ex-situ liver support; I. M???chet. Renal Replacement Therapy. Preventing end-stage renal disease: fact or fiction? B. Kasiske. Transplantation and short daily hemodialysis; J. Traeger. Comparison of survival probabilities between renal transplant recipients and patients undergoing regular dialysis: a single center prospective study; G. Segoloni. Transplantation versus dialysis in aged and type 2 diabetic patients; C. Pouteil-Noble. Pancreas Replacement Therapy. External and implantable insulin pumps: current place in the treatment of diabetes; J.L. Selam. Pancreas and islet transplantation in the treatment of type 1 diabetes; X. Martin. Perspectives in early detection and management of IDDM; C. Thivolet. Heart and Lung Replacement Therapy. Mechanical circulatory support: today's fact and future horizons; A. El-Banayosys. Intra-myocardial myoblast injection; P. M???nasch???. Ambulatory management of primary pulmonary hypertension; J.L. Vachi???ry. Cystic fibrosis: conservative management; A. Cl???ment. Emerging Transplantations and Management. Intestinal transplantation; O. Goulet. Intracerebralgrafting of fetal neuroblasts for neurodegenerative diseases: experimental bases and clinical results; M. Pechansky. Skin equivalents; O. Damour. Concluding Remarks. Public health issues from European countries; M. Manyalich. Clinical evaluation of organ transplantation in France; Y. Matillon. From Lyon to Louisville: the need for tolerance; L. Ross.
Read Less
Add this copy of Transplantation and Changing Management of Organ to cart. $12.00, very good condition, Sold by Zubal Books rated 5.0 out of 5 stars, ships from Cleveland, OH, UNITED STATES, published 2000 by Kluwer.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
246 pp., Hardcover, remainder mark to bottom edge, else very good. -If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.
Add this copy of Transplantation and Changing Management of Organ to cart. $24.71, like new condition, Sold by Fireside Bookshop rated 4.0 out of 5 stars, ships from Stroud, GLOUCESTERSHIRE, UNITED KINGDOM, published 2000 by Kluwer Academic Publishers.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Like New in No d/j as Published jacket. Size: 8vo-over 7¾"-9¾" tall; Type: Book This text, the proceedings of the 32nd International Conference on Transplantation and Clinical Immunology, held in Lyon, France, on May 25-26, 2000, addresses novel issues in terms of changing indications for transplantation in the management of organ failure, whether humans will remain the only source for organ procurement, prospects for engineering in organ replacement, and whether transplantation will remain the most appropriate approach to organ failure. Some promising treatments are approached, such as enzymic and biochemical replacement, gene therapy, tolerance induction, stem cell transplantation, and xenotransplantation. In addition to the constant improvement in conservative management of organ failure in general, ongoing research in selected fields is reported in the proceedings, such as: liver transplantation vs artificial liver; novel dialysis strategies vs evolving immunosuppression in kidney transplantation; islets transplantation and external implantable insulin pumps vs pancreas transplantation in diabetic patients and circulatory assistance and intramyocardial myoblast injection vs heart transplantation. Pivotal experience in selected emerging transplantations is included, that is, small bowel, limb, skin and neuronal transplantation. Such fascinating perspectives raise medical, economical, and ethical problems which are discussed in this book. 246pp.
Add this copy of Transplantation and Changing Management of Organ to cart. $41.48, good condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 2000 by Springer.
Add this copy of Transplantation and Changing Management of Organ to cart. $95.64, new condition, Sold by Ria Christie Books rated 4.0 out of 5 stars, ships from Uxbridge, MIDDLESEX, UNITED KINGDOM, published 2000 by Springer.
